Northstar Response™ is a liquid biopsy test designed to detect hundreds of genomic loci uniquely methylated in cancer cells. This tumor-naive assay does not require a tumor sample. Northstar Response measures the change in methylated tumor molecules which may indicate whether or not a patient is responding to therapy.